Atlas Trials

Shire

351 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Shire

RecordFirmDate
A Clinical Study of rhPTH(1-84) Treatment in Japanese Participants With Chronic Hypoparathyroidism (NCT03878953)Shire2022-08-31
A Study of Replagal in Treatment-naïve Adults With Fabry Disease (NCT04840667)Shire2021-12-28
Post Marketing Surveillance (PMS) Study for Velaglucerase Alfa (VPRIV) in India (NCT04429984)Shire2021-07-28
ARALAST NP Alpha-1 Lung Density Chronic Obstructive Pulmonary Disease-Emphysema (COPD-E) Study (NCT04440488)Shire2021-03-08
Retrospective, Observational Chart Review Study Conducted in Poland to Document the Management and Clinical Outcome of CUVITRU and HYQVIA in Pediatric Participants (< 18 Years) With Primary Immunodeficiency (PID) (NCT04636502)Shire2021-02-08
A Study of Long-Term Safety and Efficacy of Lanadelumab for Prevention of Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor (NCT04444895)Shire2021-02-05
A Study to Evaluate the Bioavailability of Teduglutide Administered Subcutaneously by Syringe Injection Versus Pen Injector in Healthy Adult Participants (NCT04465396)Shire2021-01-13
Lanadelumab in Participants Hospitalized With COVID-19 Pneumonia (NCT04460105)Shire2020-10-31
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Single Oral Dose of Maribavir Administered in Healthy Japanese Participants Compared With Matched, Healthy, Non-Hispanic, Caucasian Participants and to Assess Dose-Proportionality of 3 Doses of Maribavir in Japanese Participants (NCT04497883)Shire2020-08-07
A Study of Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or II (NCT04130191)Shire2019-12-11
A Study Comparing the Pharmacokinetics and Palatability of Two Candidate Pediatric Powder-for-Oral-Suspension Formulations of Maribavir to the Current Maribavir Tablet Formulation Administered in Healthy Adult Participants (NCT04131556)Shire2019-10-25
A Study of SHP655 (rADAMTS13) in Sickle Cell Disease (NCT03997760)Shire2019-10-21
Study of rADAMTS-13 (SHP655) in the Treatment of Participants With Acquired Thrombotic Thrombocytopenic Purpura (aTTP) (NCT03922308)Shire2019-10-09
A Study of VPRIV in Participants With Gaucher Disease Previously Treated With Other Enzyme Replacement Therapies or Substrate Reduction Therapies (NCT04094181)Shire2019-09-19
A Study of TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD) (NCT04085172)Shire2019-09-18
A Study of Lanadelumab to Prevent Hereditary Angioedema (HAE) Attacks in Children (NCT04070326)Shire2019-08-19
Drug Use Study With VYVANSE® in Australia for Binge Eating Disorder (NCT04866043)Shire2019-06-01
A Study to Determine the Bioavailability of Lanadelumab (SHP643) Administered Subcutaneously With the Prefilled Syringe and the Autoinjector in Healthy Adult Volunteer Participants. (NCT03918239)Shire2019-05-14
A Study of Intrathecal SHP611 in Children With Metachromatic Leukodystrophy (NCT03771898)Shire2019-05-13
A Study of Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or II in North America (NCT03845400)Shire2019-03-30
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Ascending, Subcutaneous, Single and Multiple Doses of SHP681 (Glucagon-like Peptide-2 [GLP-2] Analog-Fc Fusion) in Healthy Adult Participants (NCT03859323)Shire2019-03-26
Drug Use Study With Intuniv® in Australia (NCT04866030)Shire2019-03-11
Study to Evaluate the Effect of Omeprazole on the Pharmacokinetics of SPD422 (Anagrelide Hydrochloride) in Healthy Adult Participants (NCT03866434)Shire2019-02-26
Efficacy and Safety Study of Ontamalimab as Maintenance Treatment in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 307) (NCT03627091)Shire2019-02-06
FIRAZYR General Drug Use-Results Survey (Japan) (NCT04057131)Shire2018-11-20
Drug Use Study With Intuniv® in European Countries (NCT05870605)Shire2018-11-15
Safety and Efficacy Study of rhPTH(1-84) in Subjects With Hypoparathyroidism (NCT03364738)Shire2018-09-26
Safety, Efficacy and Pharmacokinetic Study of Teduglutide in Infants 4 to 12 Months of Age With Short Bowel Syndrome (NCT03571516)Shire2018-08-31
Efficacy and Safety Study of Ontamalimab as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 305) (NCT03559517)Shire2018-08-29
Efficacy and Safety Study of Ontamalimab as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 306) (NCT03566823)Shire2018-07-17
Study of Teduglutide in Japanese Participants With Short Bowel Syndrome (NCT03663582)Shire2018-07-06
Study of Midazolam Hydrochloride Oromucosal Solution (MHOS/SHP615) in Pediatric Patients With Status Epilepticus (Convulsive) in the Community Setting (NCT03336450)Shire2018-04-23
An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative Colitis (NCT03290781)Shire2018-04-04
Safety, Tolerability and Pharmacokinetics of SHP465 in Children Aged 4 to 5 Years With Attention-Deficit/Hyperactivity Disorder (ADHD) (NCT03327402)Shire2018-03-13
A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA) (NCT03283085)Shire2018-02-27
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis (NCT03259334)Shire2018-02-09
A Study to Learn if Recombinant Human Parathyroid Hormone [rhPTH(1-84)] Can Improve Symptoms and Metabolic Control in Adults With Hypoparathyroidism (BALANCE) (NCT03324880)Shire2018-01-24
Intensive Pharmacovigilance Program for Elaprase (SHP ELA-701) (NCT03582449)Shire2018-01-19
Study of Lanadelumab in Healthy Japanese and Matched Caucasian Adult Subjects (NCT03401671)Shire2018-01-15
Safety and Tolerability Study of SHP465 in Children Aged 4 to 12 Years Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) (NCT03325894)Shire2018-01-02
Efficacy and Safety of SHP465 at 6.25 mg in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-12 Years (NCT03325881)Shire2017-12-09
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis (NCT03259308)Shire2017-12-05
Open-label Study of Midazolam Hydrochloride Oromucosal Solution (MHOS/SHP615) in Children With Status Epilepticus (Convulsive) in a Healthcare Setting in Japan (NCT03336645)Shire2017-10-23
Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Participants With Eosinophilic Esophagitis (EoE) (NCT03245840)Shire2017-10-05
Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder (ADHD) (NCT03260205)Shire2017-09-06
Next →

Track Shire automatically

Every clearance here is in the API, with alerts when new ones post.